There are four FDA-approved ways to take PrEP in 2026 — two daily pills and two long-acting injections — and their prices range from about $30 a month to over $28,000 a year. That gap is enormous, but it matters far less than most people expect, because under the Affordable Care Act most insured patients pay $0 for PrEP regardless of which one they take.
This is SunnyPharma’s independent, physician-reviewed comparison of every PrEP option — generic Truvada, Descovy, Apretude, and Yeztugo — on cost, dosing, generic availability, insurance coverage, and how to pay nothing. The right choice depends on cost, how you feel about a daily pill versus an injection, and clinical factors only your prescriber can weigh.
- Generic Truvada is the only cheap option — about $30/month; the others are brand-only
- Insurance usually makes all of them $0 for PrEP — the ACA mandate covers PrEP with no cost sharing
- Descovy has no fillable generic — FDA-approved on paper, but patent-blocked from pharmacies
- Apretude and Yeztugo are injections — every 2 months and twice a year, no daily pill
- Uninsured? Free routes exist — Ready, Set, PrEP for oral PrEP, plus manufacturer assistance for the brands
- Generic Truvada has one eligibility limit — not FDA-approved for receptive-vaginal-sex-only risk
PrEP Options Compared — Cost & Dosing
| Option | Form / Dosing | Cost (no insurance) | Generic? |
|---|---|---|---|
| Generic Truvada (TDF/FTC) | Daily pill | ~$30/mo with discount card | Yes — available |
| Descovy (TAF/FTC) | Daily pill | ~$2,200/mo list | No fillable generic |
| Apretude (cabotegravir) | Injection every 2 months | ~$22,000/yr | No |
| Yeztugo (lenacapavir) | Injection twice a year | ~$28,218/yr | No |
Prices as of 2026. Injectable brand prices are set by the manufacturer; oral generic cash price varies by pharmacy.
The single most important point: if you have insurance, PrEP is generally $0 no matter which option you choose, because the ACA requires plans to cover it with no cost sharing. The huge price differences above matter most if you are uninsured — where generic Truvada (~$30) or the free Ready, Set, PrEP program is the practical low-cost route.
The Two Daily Pills: Generic Truvada vs. Descovy
Both are once-daily tablets, but they differ in formulation and — dramatically — in price.
Generic Truvada uses tenofovir disoproxil fumarate (TDF). It is FDA-approved, available at pharmacies nationwide, and costs about $30 a month with a discount card. It is the cheapest PrEP by far. Its one limitation: it is not FDA-approved for people whose only HIV risk is receptive vaginal sex.
Descovy uses tenofovir alafenamide (TAF), which may be preferred for people with kidney or bone concerns. It has no fillable U.S. generic and a list price around $2,200 a month, so its affordability depends on insurance or Gilead’s assistance programs. For the full breakdown, see our Descovy cost guide and Truvada cost guide.
The Two Injectables: Apretude vs. Yeztugo
Long-acting injectables remove the daily-pill burden — a major advantage for people who struggle with adherence — but cost far more and require clinic visits for each dose.
| Feature | Apretude | Yeztugo |
|---|---|---|
| Active drug | Cabotegravir | Lenacapavir |
| Dosing | Every 2 months | Twice a year (every 6 months) |
| FDA approved | 2021 | 2025 |
| List cost | ~$22,000/yr | ~$28,218/yr |
| Manufacturer | ViiV Healthcare | Gilead Sciences |
| Copay program (commercial) | ViiVConnect — as low as $0 (up to $7,850/yr) | Gilead Advancing Access — as low as $0 (up to $8,000/yr) |
| Generic | No | No |
Yeztugo is the newest and least frequent — one injection every six months — and was hailed as a major breakthrough in HIV prevention. Its list price is the highest at about $28,218 a year. After its 2025 approval, some insurers were slow to add it, but Gilead reports over 95% of U.S. lives are now covered, often requiring a prior authorization.
Apretude, given every two months, has an established coverage track record and a mature assistance-program safety net. It costs roughly $22,000 a year at list.
Injectable PrEP requires commitment. Once injected, these drugs stay in your body for months and cannot be removed. Missed follow-up doses can lead to drug resistance if HIV is acquired during a gap. Injectables suit people who can keep scheduled appointments; discuss the trade-offs with your provider.
How to Pay $0 for PrEP
Whichever option you and your prescriber choose, cost should rarely be the deciding factor. Here are the legitimate routes to $0, in the order most people should check them.
1. Insurance + the ACA $0 Mandate
Under the Affordable Care Act, upheld in the 2025 Braidwood decision, most commercial plans must cover recommended PrEP — medication, labs, and clinic visits — with no cost sharing. If you are being charged for PrEP with commercial insurance, that may be a billing error worth challenging.
2. Ready, Set, PrEP (uninsured, oral PrEP)
The federal Ready, Set, PrEP program provides oral PrEP medication free to people who are HIV-negative, lack prescription coverage, and have a valid prescription. Enroll at getyourprep.com or call 1-855-447-8410.
3. Manufacturer Assistance (the brands and injectables)
- Gilead Advancing Access (Descovy, Yeztugo) — copay support for commercially insured; free medication for eligible uninsured. 1-800-226-2056.
- ViiVConnect (Apretude) — copay savings up to $7,850/yr for commercially insured; patient assistance for uninsured.
4. Generic Truvada + a Discount Card
Even paying cash, generic Truvada is about $30 a month with a free discount card — often cheaper than a copay. Compare pharmacies, as generic cash prices vary.
Which PrEP Is Right for You?
- Cheapest, if you can take a daily pill: generic Truvada.
- Kidney or bone concerns, daily pill: Descovy (via insurance or assistance).
- Struggle with daily adherence, want an injection: Apretude (every 2 months) or Yeztugo (twice a year).
- Fewest appointments: Yeztugo, at twice a year.
- Only risk is receptive vaginal sex: not generic Truvada — ask about Descovy or an injectable.
PrEP is a prescription decision that requires HIV testing and monitoring. You must be HIV-negative to start and stay on PrEP, and periodic testing is required. Do not start, stop, or switch PrEP without your clinician — and never buy “PrEP” from a website offering it without a prescription.
Frequently Asked Questions
Generic Truvada (emtricitabine/tenofovir disoproxil fumarate) is by far the cheapest PrEP — about $30 a month with a discount card, versus roughly $2,200 a month for Descovy, about $22,000 a year for Apretude, and about $28,218 a year for Yeztugo. With insurance, the Affordable Care Act generally makes all of them $0 for PrEP, so the price gap matters most for uninsured people, where generic Truvada or the free Ready, Set, PrEP program is the low-cost route.
Under the Affordable Care Act, upheld in the 2025 Braidwood decision, most commercial plans must cover recommended PrEP with no cost sharing — including the medication, lab work, and clinic visits. In practice, plans cover the inexpensive generic at $0 easily, and may require a prior authorization to cover a more expensive branded or injectable option like Descovy, Apretude, or Yeztugo.
Only Truvada has an available generic. Descovy has an FDA-approved generic on paper, but patents block it from U.S. pharmacies, so it is not fillable. Apretude (cabotegravir) and Yeztugo (lenacapavir) are both brand-only with no generic. That is why generic Truvada is the only low-cost option, and the branded and injectable options depend on insurance or manufacturer assistance to be affordable.
Yeztugo has a U.S. list price of about $28,218 per year, covering its twice-yearly injections. Most commercially insured patients can pay as little as $0 through Gilead’s Advancing Access copay program (up to $8,000 per year in assistance), and uninsured patients may qualify for free Yeztugo through Gilead’s Patient Assistance Program. Insurance coverage lagged after its 2025 approval, but Gilead reports over 95% of U.S. lives are now covered — often with a prior authorization.
Apretude (cabotegravir), given every two months, has a retail cost of roughly $22,000 per year. Eligible commercially insured patients can pay as little as $0 through the ViiVConnect Savings Program (up to $7,850 per year, plus administration-fee help), and uninsured patients may qualify for free Apretude through ViiV’s assistance program. Medicare and Medicaid cover it under the PrEP national coverage rules.
It depends on cost, adherence, and clinical fit. Oral generic Truvada is cheapest and effective if taken daily, but relies on adherence. Injectables (Apretude every two months, Yeztugo twice a year) remove the daily-pill burden and can suit people who struggle with adherence, but cost far more and require clinic visits for injection. There are also eligibility differences — for example, generic Truvada is not FDA-approved for people whose only risk is receptive vaginal sex. Your prescriber determines the right fit.
Often, yes. The federal Ready, Set, PrEP program provides oral PrEP medication free to qualifying uninsured people who are HIV-negative with a valid prescription. Generic Truvada is about $30 a month even paying cash with a discount card. For the branded and injectable options, manufacturer patient assistance programs (Gilead Advancing Access, ViiVConnect) provide the medication free to eligible uninsured patients. Lab tests and clinic visits may still carry costs depending on where you receive care.
No. Generic Truvada (TDF/FTC) is approved for PrEP for most at-risk groups, but it is not FDA-approved for people whose only HIV risk is receptive vaginal sex. If that applies to you, Descovy or an injectable may be necessary, and cost then depends on insurance or an assistance program rather than the cheap generic. Your prescriber will determine the right option.
How we reviewed this article:
SunnyPharma follows strict sourcing guidelines and relies on peer-reviewed studies, government agencies (FDA, CDC, DHHS, HRSA), academic research institutions, and medical associations. We use only credible, verifiable sources to ensure accuracy.
Read our editorial policy →Sources & References
- CDC. Preexposure Prophylaxis (PrEP) for the Prevention of HIV. cdc.gov
- US DHHS Panel on Antiretroviral Guidelines. clinicalinfo.hiv.gov
- Ready, Set, PrEP — federal PrEP medication assistance program. getyourprep.com
- Gilead Sciences. Descovy list price information. gileadpriceinfo.com
- FDA approves Gilead’s Yeztugo (lenacapavir); list price $28,218/yr. CNBC, June 2025.
- Gilead. Yeztugo (lenacapavir) Coverage & Cost Support. yeztugo.com
- Apretude (cabotegravir) prices & ViiVConnect savings program. drugs.com
- GoodRx. Emtricitabine/tenofovir DF (generic Truvada) pricing. goodrx.com
- FDA Orange Book — generic approvals & patent/exclusivity data. accessdata.fda.gov